摘要
背景:在过去的几十年中,大量的抗惊厥药物已被纳入治疗癫痫的药物集合中。然而,治疗中的两个主要困难仍未解决:耐药性癫痫的发展和药物对反应性患者的严重毒性反应的发生。对发现已知抗惊厥药物的策略的回顾性分析表明,对癫痫动物模型的筛选活动几乎是识别已上市化合物的唯一策略。然而,关于抗惊厥药物分子靶点的实际结构和功能信息以及对引起癫痫发作的分子改变的日益了解,可以更合理地识别活性化合物。目标:本综述汇编了用于发现新的抗惊厥候选药物的基于目标的策略,分为两个主要主题。第一个概述了计算方法(基于对接的虚拟筛选和分子动力学)以寻找与电压门控离子通道和酶碳酸酐酶相互作用的抗惊厥结构。第二个包括分析合成的活性化合物,通过抗惊厥药物的药效团组合同时作用于不同的分子靶标。 结论:目前对抗惊厥药靶点结构的了解使计算模拟成为发现和优化活性化合物的有吸引力的方法。将通过虚拟筛选不同靶标所获得的结果结合起来,可以产生多靶标化合物,作为合并已知药物支架的结构设计的替代方案。
关键词: 抗惊厥药物、癫痫、电压门控离子通道、碳酸酐酶、对接、虚拟筛选、多靶点药物、混合分子。
Current Medicinal Chemistry
Title:Computational and Synthetic Target-based Approaches to the Discovery of Novel Anticonvulsant Compounds
Volume: 28 Issue: 33
关键词: 抗惊厥药物、癫痫、电压门控离子通道、碳酸酐酶、对接、虚拟筛选、多靶点药物、混合分子。
摘要:
Background: During the past decades, an important number of anticonvulsant drugs have been incorporated into the collection of drugs to treat epilepsy. However, two main difficulties remain unsolved in therapy: the development of drug-resistant epilepsy and the occurrence of severe toxic effects caused by the medication in responsive patients. The retrospective analysis of the strategies for discovering known anticonvulsant drugs showed that screening campaigns on animal models of epilepsy have been almost the exclusive strategy for identifying the marketed compounds. However, the actual structural and functional information about the molecular targets of the anticonvulsant drugs and the increasing knowledge of the molecular alterations that generate epileptic seizures allow a more rational identification of active compounds.
Objective: This review compiles target-based strategies used for the discovery of new anticonvulsant candidates and is divided in two main topics. The first one provides an overview of the computational approaches (docking-based virtual screening and molecular dynamics) to find anticonvulsant structures that interact with the voltage-gated ion channels and the enzyme carbonic anhydrase. The second one includes the analysis of active compounds synthesized to act simultaneously on different molecular targets by the combination of pharmacophores of anticonvulsant drugs.
Conclusion: Current knowledge of the architectures of anticonvulsant targets makes computational simulations attractive methods for the discovery and optimization of active compounds. Combining the results achieved by virtual screening of different targets could lead to multitarget compounds, as an alternative to the design of structures that merge scaffolds of known drugs.
Export Options
About this article
Cite this article as:
Computational and Synthetic Target-based Approaches to the Discovery of Novel Anticonvulsant Compounds, Current Medicinal Chemistry 2021; 28 (33) . https://dx.doi.org/10.2174/0929867328666210506161234
DOI https://dx.doi.org/10.2174/0929867328666210506161234 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Therapeutic Efficacy of Selegiline in Neurodegenerative Disorders and Neurological Diseases
Current Drug Targets Genes, Blame and Loss of Control: is there a Place in Criminal Law for a ‘Genetic Defense’?
Recent Advances in DNA & Gene Sequences (Discontinued) Novel Insights into V-ATPase Functioning: Distinct Roles for its Accessory Subunits ATP6AP1/Ac45 and ATP6AP2/(pro) Renin Receptor
Current Protein & Peptide Science Hallucinations Associated with Topiramate Therapy: A Case Report and Review of the Literature
Current Drug Safety The Genetic Components of Alcohol and Nicotine Co-Addiction: From Genes to Behavior
Current Drug Abuse Reviews A Glance Over the Cannabinoid Machinery to Design New Anti- Angiogenic Compounds
Mini-Reviews in Medicinal Chemistry Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder
Current Neuropharmacology Synthesis, Molecular Modeling and Biological Evaluation of 5-arylidene-N,N-diethylthiobarbiturates as Potential α-glucosidase Inhibitors
Medicinal Chemistry Epigenetic Regulation of Trinucleotide Repeat Expansions and Contractions and the “Biased Embryos” Hypothesis for Rapid Morphological Evolution
Current Genomics Drug Treatment of Epilepsy: From Serendipitous Discovery to Evolutionary Mechanisms
Current Medicinal Chemistry A Compendium of Volatile Organic Compounds (VOCs) Released By Human Cell Lines
Current Medicinal Chemistry Cytotoxicity and Anti-proliferative Properties of Heterocyclic Compounds Derived from Progesterone
Anti-Cancer Agents in Medicinal Chemistry Neurochemical Markers in the Mammalian Brain: Structure, Roles in Synaptic Communication, and Pharmacological Relevance
Current Medicinal Chemistry Heart Rate Variability Based Prediction of Personalized Drug Therapeutic Response: The Present Status and the Perspectives
Current Topics in Medicinal Chemistry Trigonelline: A Plant Alkaloid with Therapeutic Potential for Diabetes and Central Nervous System Disease
Current Medicinal Chemistry Pharmacophore Identification and Quantitative Bioactivity Prediction Using the Electron-Conformational Method
Current Pharmaceutical Design Thymoquinone: Major Molecular Targets, Prominent Pharmacological Actions and Drug Delivery Concerns
Current Bioactive Compounds An Update on GABA Analogs for CNS Drug Discovery
Recent Patents on CNS Drug Discovery (Discontinued) Gene and Gene-Environment Risk Factors in Sudden Undexpected Death in Infants
Current Pediatric Reviews Role of Methylene Blue in Trauma Neuroprotection and Neuropsychiatric Diseases
CNS & Neurological Disorders - Drug Targets